Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nir Drayman

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|January 15, 2025
Herpesviruses mimic zygotic genome activation to promote viral replicationEva Neugebauer, Stephanie Walter, Jiang Tan, et al.
Research Square|June 9, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Biotechnology|October 10, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targetsYadi Zhou, Yuan Liu, Shagun Gupta, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune ResponseLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Biorxiv : the Preprint Server for Biology|July 13, 2022
SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cellsLong C Nguyen, David M Renner, Diane Silva, et al.
Mbio|September 20, 2022
SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived CellsLong C Nguyen, David M Renner, Diane Silva, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Science Advances|January 20, 2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Nature Communications|January 15, 2025
Herpesviruses mimic zygotic genome activation to promote viral replicationEva Neugebauer, Stephanie Walter, Jiang Tan, et al.
Research Square|June 9, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome network identifies pathobiology and host-targeting therapies for COVID-19Yadi Zhou, Yuan Liu, Shagun Gupta, et al.
Nature Biotechnology|October 10, 2022
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targetsYadi Zhou, Yuan Liu, Shagun Gupta, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune ResponseLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Biorxiv : the Preprint Server for Biology|July 13, 2022
SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cellsLong C Nguyen, David M Renner, Diane Silva, et al.
Mbio|September 20, 2022
SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived CellsLong C Nguyen, David M Renner, Diane Silva, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
Science Advances|January 20, 2022
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesLong Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, et al.
Science (New York, N.Y.)|July 21, 2021
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2Nir Drayman, Jennifer K DeMarco, Krysten A Jones, et al.
Pageof 4